JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB9524

Anti-CD44 抗体 [MEM-263]

Anti-CD44 antibody [MEM-263]

Be the first to review this product! Submit a review

|

(12 Publications)

Mouse Monoclonal CD44 antibody. Suitable for IHC-P, Flow Cyt, WB and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Cell preparation containing CD44 protein.

別名を表示する

CD44, LHR, MDU2, MDU3, MIC4, CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, ECMR-III, PGP-1, PGP-I

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [MEM-263] (AB9524)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [MEM-263] (AB9524)

IHC image of CD44 staining in Human Skin Melanoma formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab9524, 0.5 μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Flow Cytometry - Anti-CD44 antibody [MEM-263] (AB9524)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-CD44 antibody [MEM-263] (AB9524)

Human peripheral blood lymphocytes stained with ab9524 (red line). Human whole blood was processed using a modified protocol based on Chow et al, 2005 (PMID : 16080188). In brief, human whole blood was fixed in 4% formaldehyde (methanol-free) for 10 min at 22°C. Red blood cells were then lyzed by the addition of Triton X-100 (final concentration - 0.1%) for 15 min at 37°C. For experimentation, cells were treated with 50% methanol (-20°C) for 15 min at 4°C. Cells were then incubated with the antibody (ab9524, 0.1μg/1x106 cells) for 30 min at 4°C. The secondary antibody used was Alexa Fluor® 488 goat anti-mouse IgG (H&L) (ab150113) at 1/2000 dilution for 30 min at 4°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >30,000 total events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. Gating strategy - peripheral blood lymphocytes.

Western blot - Anti-CD44 antibody [MEM-263] (AB9524)
  • WB

Lab

Western blot - Anti-CD44 antibody [MEM-263] (AB9524)

Lanes 1 - 4 : Merged signal (red and green). Green - ab9524 observed at 80 kDa. Red - loading control, ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) observed at 55kDa.

ab9524 was shown to react with CD44 in wild-type HeLa cells in western blot. Loss of signal was observed when CD44 knockout sample was used. Wild-type and CD44 knockout HeLa cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab9524 and ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) overnight at 4°C at 2 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CD44 antibody [MEM-263] (ab9524) at 2 µg/mL

Lane 1:

Wild-type HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 2:

CD44 knockout HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 2:

Western blot - Human CD44 knockout HeLa cell line (<a href='/products/cell-lines/human-cd44-knockout-hela-cell-line-ab262515'>ab262515</a>)

Lane 3:

A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg

Lane 4:

LNCaP (Human prostate cancer cell line) whole cell lysate at 20 µg

Predicted band size: 81 kDa

Observed band size: 80 kDa

false

Western blot - Anti-CD44 antibody [MEM-263] (AB9524)
  • WB

Unknown

Western blot - Anti-CD44 antibody [MEM-263] (AB9524)

Western blotting of HPB-ALL cell lysate (non-reduced sample) stained by ab9524. Western blotting of HPB-ALL cell lysate (non-reduced sample) stained by ab9524.

All lanes:

Western blot - Anti-CD44 antibody [MEM-263] (ab9524)

Predicted band size: 81 kDa

false

Western blot - Anti-CD44 antibody [MEM-263] (AB9524)
  • WB

Supplier Data

Western blot - Anti-CD44 antibody [MEM-263] (AB9524)

All lanes:

Western blot - Anti-CD44 antibody [MEM-263] (ab9524) at 2 µg/mL

Lane 1:

MOLT-4 cells (human T lymphoblast; acute lymphoblastic leukemia)

Lane 2:

HeLa cells (human epithelial cell line from cervix adenocarcinoma)

Predicted band size: 81 kDa

false

関連する標識済み抗体及び組成の異なる製品 (3)

  • 660 APC

    APC Anti-CD44 antibody [MEM-263]

  • 519 FITC

    FITC Anti-CD44 antibody [MEM-263]

  • 578 PE

    PE Anti-CD44 antibody [MEM-263]

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

MEM-263

アイソタイプ

IgG1

キャリアフリー

No

交差種

Human

アプリケーション

Flow Cyt, WB, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

エピトープ

extracellular (N-terminal) domain

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "10 µg/mL", "IHCP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "4 µg/mL", "FlowCyt-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2 µg/mL", "WB-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
精製に関する特記事項
Purified from TCS. Purity >95% by SDS-PAGE.
バッファー組成
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Cell-surface receptor that plays a role in cell-cell interactions, cell adhesion and migration, helping them to sense and respond to changes in the tissue microenvironment (PubMed : 16541107, PubMed : 19703720, PubMed : 22726066). Participates thereby in a wide variety of cellular functions including the activation, recirculation and homing of T-lymphocytes, hematopoiesis, inflammation and response to bacterial infection (PubMed : 7528188). Engages, through its ectodomain, extracellular matrix components such as hyaluronan/HA, collagen, growth factors, cytokines or proteases and serves as a platform for signal transduction by assembling, via its cytoplasmic domain, protein complexes containing receptor kinases and membrane proteases (PubMed : 18757307, PubMed : 23589287). Such effectors include PKN2, the RhoGTPases RAC1 and RHOA, Rho-kinases and phospholipase C that coordinate signaling pathways promoting calcium mobilization and actin-mediated cytoskeleton reorganization essential for cell migration and adhesion (PubMed : 15123640). Upon interaction with LGALS9 ligand, activates downstream signaling components including LCK, ERK and MAPK to promotes NK cell activation (PubMed : 37006235).. (Microbial infection) Promotes foot-and-mouth disease virus internalization via macropinocytosis.
See full target information CD44

文献 (12)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 15:1479458 PubMed39872532

2025

The bronchoalveolar lavage fluid as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases.

Applications

Unspecified application

Species

Unspecified reactive species

Magda Suchankova,Eszter Zsemlye,Jan Urban,Peter Baráth,Lenka Kohútová,Barbara Siváková,Martina Ganovska,Elena Tibenska,Kinga Szaboova,Eva Tedlova,Dominik Juskanic,Kristina Kluckova,Michaela Kardohelyova,Tetiana Moskalets,Anna Ohradanova-Repic,Patrik Babulic,Maria Bucova,Vladimir Leksa

STAR protocols 4:102177 PubMed37086411

2023

Protocol for indirect and direct co-culture between human cancer cells and endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yichen Guo,Bronte Miller,Michael Heim,Ana Gutierrez-Garcia,Renata Jaskula-Sztul,Bin Ren,Mary Kathryn Sewell-Loftin

International journal of molecular sciences 23: PubMed35628262

2022

CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?

Applications

Unspecified application

Species

Unspecified reactive species

Ruizhi Geng,Niklas Harland,Ivonne A Montes-Mojarro,Falko Fend,Wilhelm K Aicher,Arnulf Stenzl,Bastian Amend

International journal of molecular sciences 23: PubMed35563359

2022

Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation.

Applications

Unspecified application

Species

Unspecified reactive species

Niklas Harland,Florian B Maurer,Tanja Abruzzese,Cornelia Bock,Ivonne A Montes-Mojarro,Falko Fend,Wilhelm K Aicher,Arnulf Stenzl,Bastian Amend

Journal of nanobiotechnology 20:150 PubMed35305656

2022

Triamcinolone acetonide-loaded nanoparticles encapsulated by CD90 MCSs-derived microvesicles drive anti-inflammatory properties and promote cartilage regeneration after osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanlong Li,Qingqiang Tu,Dongmei Xie,Shurui Chen,Kai Gao,Xiaochun Xu,Ziji Zhang,Xifan Mei

Experimental & molecular medicine 53:291-299 PubMed33603128

2021

Analysis of transient membrane protein interactions by single-molecule diffusional mobility shift assay.

Applications

Unspecified application

Species

Unspecified reactive species

Min Gyu Jeong,Kai Zhou,Soyeon Park,HyeongJeon An,Yonghoon Kwon,Yeonho Chang,Do-Hyeon Kim,Sung Ho Ryu

Oral diseases 27:1383-1393 PubMed32593227

2020

Oral cancer stem cells drive tumourigenesis through activation of stromal fibroblasts.

Applications

Unspecified application

Species

Unspecified reactive species

Mohanad J N Al-Magsoosi,Daniel W Lambert,Syed Ali Khurram,Simon A Whawell

Biology of reproduction 98:752-764 PubMed29546322

2018

Idiopathic infertility in women is associated with distinct changes in proliferative phase uterine fluid proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Harriet C Fitzgerald,Jemma Evans,Nicholas Johnson,Giuseppe Infusini,Andrew Webb,Luk J R Rombauts,Beverley J Vollenhoven,Lois A Salamonsen,Tracey A Edgell

Scientific reports 5:9447 PubMed25819560

2015

The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice.

Applications

IHC-P

Species

Unspecified reactive species

Lianhai Zhang,Yiqiang Liu,Xiaohong Wang,Zhiyu Tang,Shuangxi Li,Ying Hu,Xianglong Zong,Xiaojiang Wu,Zhaode Bu,Aiwen Wu,Ziyu Li,Zhongwu Li,Xiaozheng Huang,Ling Jia,Qiang Kang,Yong Liu,David Sutton,Lai Wang,Lusong Luo,Jiafu Ji

Molecular cancer therapeutics 11:2384-93 PubMed22933702

2012

Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.

Applications

Unspecified application

Species

Human

Mona Samy,Charles-Henry Gattolliat,Frédéric Pendino,Josette Hillion,Eric Nguyen,Sophie Bombard,Sétha Douc-Rasy,Jean Bénard,Evelyne Ségal-Bendirdjian
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com